Akcea Therapeutics, Inc. Finite-Lived Intangible Assets, Net
Akcea Therapeutics, Inc. had Finite-Lived Intangible Assets, Net of $80.13 million as of 2020-06-30, per its 10-Q filed 2020-08-05.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2020-08-05
- 2020-06-30: Finite-Lived Intangible Assets, Net $80.13M.
- 2020-03-31: Finite-Lived Intangible Assets, Net $81.59M.
- 2019-12-31: Finite-Lived Intangible Assets, Net $83.05M.
- 2019-09-30: Finite-Lived Intangible Assets, Net $84.53M.
| Period end | Finite-Lived Intangible Assets, Net |
|---|---|
| 2020-06-30 | $80.13M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $81.59M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $83.05M 10-Q · filed 2020-08-05 |
| 2019-09-30 | $84.53M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $86.01M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $87.47M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $88.91M 10-K · filed 2020-03-02 |
| 2018-09-30 | $40.97M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $1.71M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $1.19M 10-Q · filed 2018-05-07 |
| 2017-12-31 | $1.22M 10-K · filed 2019-03-01 |
| 2016-12-31 | $1.34M 8-K · filed 2018-09-18 |